Literature DB >> 19049963

Regulation of RAF activity by 14-3-3 proteins: RAF kinases associate functionally with both homo- and heterodimeric forms of 14-3-3 proteins.

Andreas Fischer1, Angela Baljuls, Joerg Reinders, Elena Nekhoroshkova, Claudia Sibilski, Renate Metz, Stefan Albert, Krishnaraj Rajalingam, Mirko Hekman, Ulf R Rapp.   

Abstract

Mammalian 14-3-3 proteins play a crucial role in the activation process of RAF kinases. However, little is known about the selectivity of the mammalian 14-3-3 isoforms with respect to RAF association and activation. Using mass spectrometry, we analyzed the composition of the 14-3-3 isoforms attached to RAF kinases and found that B-RAF associates in vivo with 14-3-3 at much higher diversity than A- and C-RAF. We also examined in vitro binding of purified mammalian 14-3-3 proteins to RAF kinases using surface plasmon resonance techniques. While B- and C-RAF exhibited binding to all seven 14-3-3 isoforms, A-RAF bound with considerably lower affinities to epsilon, tau, and sigma 14-3-3. These findings indicate that 14-3-3 proteins associate with RAF isoforms in a pronounced isoform-specific manner. Because 14-3-3 proteins appear in dimeric forms, we addressed the question of whether both homo- and heterodimeric forms of 14-3-3 proteins participate in RAF signaling. For that purpose, the budding yeast Saccharomyces cerevisiae, possessing only two 14-3-3 isoforms (BMH1 and BMH2), served as testing system. By deletion of the single BMH2 gene, we found that both homo- and heterodimeric forms of 14-3-3 can participate in RAF activation. Furthermore, we show that A-, B-, and C-RAF activity is differentially regulated by its C-terminal and internal 14-3-3 binding domain. Finally, prohibitin, a scaffold protein that affects C-RAF activation in a stimulatory manner, proved to interfere with the internal 14-3-3 binding site in C-RAF. Together, our results shed more light on the complex mechanism of RAF activation, particularly with respect to activation steps that are mediated by 14-3-3 proteins and prohibitin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19049963     DOI: 10.1074/jbc.M804795200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.

Authors:  Chi Zhang; Li-Xin Liu; Zhao-Ru Dong; Guo-Ming Shi; Jia-Bin Cai; Peng-Fei Zhang; Ai-Wu Ke; Jing-Xian Yu; Jian Zhou; Jia Fan
Journal:  Tumour Biol       Date:  2014-11-13

2.  Increased cell proliferation and differential protein expression induced by low-level Er:YAG laser irradiation in human gingival fibroblasts: proteomic analysis.

Authors:  Mayumi Ogita; Sachio Tsuchida; Akira Aoki; Mamoru Satoh; Sayaka Kado; Masanori Sawabe; Hiromi Nanbara; Hiroaki Kobayashi; Yasuo Takeuchi; Koji Mizutani; Yoshiyuki Sasaki; Fumio Nomura; Yuichi Izumi
Journal:  Lasers Med Sci       Date:  2014-11-28       Impact factor: 3.161

3.  14-3-3 proteins mediate the localization of Centrin2 to centrosome.

Authors:  Arunabha Bose; Sorab N Dalal
Journal:  J Biosci       Date:  2019-06       Impact factor: 1.826

4.  Impaired binding of 14-3-3 to C-RAF in Noonan syndrome suggests new approaches in diseases with increased Ras signaling.

Authors:  Manuela Molzan; Benjamin Schumacher; Corinna Ottmann; Angela Baljuls; Lisa Polzien; Michael Weyand; Philipp Thiel; Rolf Rose; Micheline Rose; Philipp Kuhenne; Markus Kaiser; Ulf R Rapp; Jürgen Kuhlmann; Christian Ottmann
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

5.  14-3-3γ binds regulator of G protein signaling 14 (RGS14) at distinct sites to inhibit the RGS14:Gαi-AlF4- signaling complex and RGS14 nuclear localization.

Authors:  Kyle J Gerber; Katherine E Squires; John R Hepler
Journal:  J Biol Chem       Date:  2018-08-09       Impact factor: 5.157

6.  Discrete cytosolic macromolecular BRAF complexes exhibit distinct activities and composition.

Authors:  Britta Diedrich; Kristoffer Tg Rigbolt; Michael Röring; Ricarda Herr; Stephanie Kaeser-Pebernard; Christine Gretzmeier; Robert F Murphy; Tilman Brummer; Jörn Dengjel
Journal:  EMBO J       Date:  2017-01-16       Impact factor: 11.598

Review 7.  Emerging modes-of-action in drug discovery.

Authors:  Eric Valeur; Frank Narjes; Christian Ottmann; Alleyn T Plowright
Journal:  Medchemcomm       Date:  2019-06-25       Impact factor: 3.597

8.  14-3-3 proteins mediate inhibitory effects of cAMP on salt-inducible kinases (SIKs).

Authors:  Tim Sonntag; Joan M Vaughan; Marc Montminy
Journal:  FEBS J       Date:  2018-01-09       Impact factor: 5.542

9.  Diacylglycerol kinase eta augments C-Raf activity and B-Raf/C-Raf heterodimerization.

Authors:  Satoshi Yasuda; Masahiro Kai; Shin-Ichi Imai; Kazuki Takeishi; Akinobu Taketomi; Minoru Toyota; Hideo Kanoh; Fumio Sakane
Journal:  J Biol Chem       Date:  2009-08-26       Impact factor: 5.157

10.  B-Raf and CRHR1 internalization mediate biphasic ERK1/2 activation by CRH in hippocampal HT22 Cells.

Authors:  Juan J Bonfiglio; Carolina Inda; Sergio Senin; Giuseppina Maccarrone; Damián Refojo; Damiana Giacomini; Christoph W Turck; Florian Holsboer; Eduardo Arzt; Susana Silberstein
Journal:  Mol Endocrinol       Date:  2013-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.